Forecast: Diabetes Medicine Use in Australia

Diabetes medicine use in Australia has shown a complex trend over the past decade, marked by periods of stability and notable increases in recent years. In 2023, the use stood at 65.4 units of Defined Daily Dosage per thousand persons per day. Initially, values remained steady around 57.5 units until 2016, with minor fluctuations afterward. A marked increase started from 2020, leading to a Compound Annual Growth Rate (CAGR) of 2.5% over the last five years. Recent year-on-year changes show a continuation of this upward trend, with 2.19% growth in 2023.

For future trends, observe:

• Continued steady increase in diabetes medicine use, projected to reach 71.3 units by 2028, reflecting a forecasted CAGR of 1.31% over the next five years.
• Potential influences from emerging diabetes treatments and policy changes in the healthcare system.
• Demographic shifts and lifestyle changes impacting diabetes prevalence and treatment demand.